免疫检查点抑制剂和类风湿性关节炎:所有道路都通向PD-1?
1Johns Hopkins School of Medicine, Division of Rheumatology, 5501 Hopkins Bayview Circle, Suite 1B1, Baltimore, MD 21212, USA..
Seminars in arthritis and rheumatism
|November 22, 2024
概括
针对PD-1/PD-L1通路的免疫检查点抑制剂和激动剂为类风湿性关节炎 (RA) 的治疗和管理提供了新的途径. 了解这些途径对于风湿病学家在涉及RA患者的各种临床场景中至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 在瘤学瘤学.
背景情况:
- 免疫检查点分子,包括PD-1,PD-L1和CTLA-4,是免疫反应的关键调节者.
- 针对这些途径的免疫检查点抑制剂 (ICI) 是已知的癌症疗法.
- 激活免疫检查点的药物,如阿巴塔cept,用于自身免疫性疾病.
研究的目的:
- 探索PD-1/PD-L1轴在风湿病学中的多方面的作用.
- 突出PD-1/PD-L1调制在类风湿性关节炎 (RA) 中的临床相关性.
- 确定PD-1/PD-L1治疗在炎症性关节炎的临床和翻译研究中的未回答问题.
主要方法:
- 对免疫检查点抑制剂和激动剂的当前文献的综述.
- 在RA患者中分析涉及PD-1/PD-L1通路的临床场景.
- 讨论针对PD-1/PD-L1轴的治疗方法的并行开发.
主要成果:
- 针对RA治疗,PD-1激动剂正在开发中.
- 关节炎患者可能会接受癌症的ICI治疗,需要进行类风湿治疗.
- ICI治疗可能导致新发炎性关节炎.
结论:
- 对于风湿病学家来说,调节PD-1/PD-L1轴对于治疗RA患者至关重要.
- PD-1/PD-L1抗剂和激动剂的双重发展为炎症性关节炎的研究提供了独特的机会.
- 需要进一步的临床和翻译研究来解决目前的知识差距.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142


